The Board proposes to open the rule for development to comprehensively review the rule for any necessary or needed technical or substantive changes, and for the specific purpose of determining the necessity of incorporating and setting as the ...

 

DEPARTMENT OF HEALTH

Board of Pharmacy

RULE NO.:RULE TITLE:

64B16-27.797Standards of Practice for Compounding Sterile Preparations (CSPs)

PURPOSE AND EFFECT: The Board proposes to open the rule for development to comprehensively review the rule for any necessary or needed technical or substantive changes, and for the specific purpose of determining the necessity of incorporating and setting as the minimum standards to follow when compounding sterile products, the following chapters of the United States Pharmacopeia: 797; 1160; 71; 85; 731; 1035; 1116; 1211; and 1231.

SUBJECT AREA TO BE ADDRESSED: Standards of Practice for Compounding Sterile Preparations (CSPs).

RULEMAKING AUTHORITY: 465.005, 465.0155, 465.022 FS.

LAW IMPLEMENTED: 465.0155, 465.022 FS.

IF REQUESTED IN WRITING AND NOT DEEMED UNNECESSARY BY THE AGENCY HEAD, A RULE DEVELOPMENT WORKSHOP WILL BE NOTICED IN THE NEXT AVAILABLE FLORIDA ADMINISTRATIVE REGISTER.

THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: Tammy Collins, Acting Executive Director, Board of Pharmacy, 4052 Bald Cypress Way, Bin C04, Tallahassee, Florida 32399-3254

THE PRELIMINARY TEXT OF THE PROPOSED RULE DEVELOPMENT IS NOT AVAILABLE.